Sickle Cell and Thalassemia Program
The Comprehensive Sickle Cell and Thalassemia Program is home to over 280 children, adolescents and young adults, with sickle cell anemia and other disorders of hemoglobin including beta thalassemia, emphasizing primary, secondary and tertiary prevention and treatment using a multidisciplinary team approach. Children’s program is recognized as one of six selected clinical centers for the management of children with sickle cell anemia by the Ohio Department of health, and oversees newborn screening, counseling, clinical management of acute complications and long-term follow-up care for the largest region of the state.
The division of Hematology, Oncology & Blood and Marrow Transplant is ranked in the Top 10 by US News and World Report.
Children’s highly specialized services include state-of-the-art screening and management of cerebrovasular, neurologic, cardiac and hepatobiliary complications. Our experts also provide complete transfusion support services, iron overload management, clinical psychological testing and follow-up, diagnostic testing and counseling and bone marrow transplantation. We are a leader in quality of life research in sickle cell anemia and participate in a variety of federally-funded clinical trials in sickle cell and thalassemia. This physician lead team includes a nurse practitioner, social worker, psychologist, nutritionist, nurse clinician, program coordinator, pastoral care and newborn screening coordinator.
The Sickle Cell Disease and Thalassemia Clinic focuses on the needs of children, adolescents and adults who have sickle cell disease, thalassemia and other inherited red blood cell disorders.
The clinic is staffed by board certified hematologists/oncologists Dr. Anthony Villella, Dr. Susan Creary, and Jennifer Young, a Certified Nurse Practitioner. During their clinic visit, the pediatric patient with sickle cell disease is seen by a physician, nurse practitioner, nurse clinician, social worker, psychologist, a dentist, and a genetics counselor. Patients along with their families receive education about these illnesses and are counseled on potential therapies. Physical examinations and screenings are completed during each clinic visit to find early signs of complications from the disease so effective treatment can be implemented. Our program is dedicated to providing the highest quality of care and education in a manner that respects the cultural diversity of the community we serve.
Sickle Cell Comprehensive Clinic
Nationwide Children's Hospital
700 Children's Drive
Columbus, Ohio 43205
Amy L. Dunn
Amy Dunn, MD is the Director of Pediatric Hematology and directs the Hemophilia Treatment Center.
Jeffery J. Auletta
Jeffery Auletta, MD, is the Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases (HD) Program at Nationwide Children's Hospital.
Cancer Clinical Research
Learn more about clinical research relating to cancer.
Sickle Cell Anemia Clinical Research
Learn more about clinical research relating to sickle cell anemia.
Hematologic disorders are conditions found in the blood and blood forming organs. This includes blood cell cancers, genetic disorders, anemia, HIV related conditions, sickle cell disease, and complications do to chemotherapy treatment or transfusions.
Hematology and Oncology Outpatient Clinic
The Hematology and Oncology Outpatient Clinic is designed to be a link between the family, home and the hospital.
Musculoskeletal Oncology Program
Our Musculoskeletal Oncology Program focuses on innovative limb salvage strategies and ways to protect quality of life both now and in the future for our patients.
CureSearch for Children’s Cancer’s mission is to end children’s cancer by driving targeted and innovative research with measurable results in an accelerated time frame.
Hemostasis and Thrombosis Research Society
HTRS is a North American professional medical society dedicated to advancing care for people with bleeding and thrombotic disorders through investigator-initiated research, mentoring, and continuing medical education.
Making Stem Cell Transplantation Work for Sickle Cell Disease
New regimen offers a promising approach for unrelated donor transplants.